• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 9
  • 6
  • 1
  • 1
  • Tagged with
  • 17
  • 17
  • 6
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
11

Tissue-Selective Activation and Toxicity of Substituted Dichlorobenzenes : Studies on the Mechanism of Cell Death in the Olfactory Mucosa

Franzén, Anna January 2005 (has links)
<p>The nasal passages are constantly exposed to both air- and bloodborne foreign compounds. In particular, the olfactory mucosa is demonstrated to be susceptible to a variety of drugs and chemicals. In this thesis, mechanisms involved in tissue-selective toxicity in the olfactory mucosa of rodents have been investigated using the olfactory toxicant 2,6-dichlorophenyl methylsulphone (2,6-diClPh-MeSO<sub>2</sub>) as a model compound. Comparative studies were performed with the non-toxic 2,5-dichlorophenyl methylsulphone (2,5-diClPh-MeSO<sub>2</sub>) and the reasons for the strikingly different toxicity were investigated. </p><p>A strong bioactivation and protein adduction of 2,6-diClPh-MeSO<sub>2</sub> in olfactory microsomes and S9-fractions of rodents was demonstrated. In contrast, no significant metabolic activation of 2,5-diClPh-MeSO<sub>2</sub> was observed and the bioactivation in the liver for both chlorinated isomers was negligible. <i>In vitro</i> studies with recombinant yeast cell microsomes expressing mouse cytochrome P450 2A5 (CYP2A5) demonstrated a metabolic activation of 2,6-diClPh-MeSO<sub>2</sub>. The 2,6-diClPh-MeSO<sub>2</sub>-induced lesions and CYP2A5 expression preferentially occurred in Bowman’s glands and sustentacular cells of the olfactory mucosa. A significant depletion of glutathione (GSH) in the olfactory mucosa was demonstrated <i>in vivo</i>, while no changes were observed in the liver. There was a rapid induction of the endoplasmic reticulum (ER)-specific chaperone Grp78, activation of the ER-specific caspase-12 and the downstream caspase-3 in the Bowman’s glands. Electron microscopy revealed swelling of ER and mitochondria and a lost integrity of the Bowman’s glands. </p><p>Based on these results, the proposed mechanism for 2,6-diClPh-MeSO<sub>2</sub>-induced toxicity in the olfactory mucosa is bioactivation by CYP2A5 into a reactive intermediate causing protein adduction and GSH-depletion. This is initiating a sequence of downstream events of ER-stress, changes in ion homeostasis, ultrastructural organelle disruption and apoptotic signalling. In spite of the initial apoptotic signals, the terminal phase of apoptosis seemed to be blocked and necrotic features occurred. The predominant expression of CYP2A5 in the olfactory mucosa is proposed to play a key role for the tissue- and cell-specific toxicity induced by 2,6-diClPh-MeSO<sub>2</sub>.</p>
12

Tissue-Selective Activation and Toxicity of Substituted Dichlorobenzenes : Studies on the Mechanism of Cell Death in the Olfactory Mucosa

Franzén, Anna January 2005 (has links)
The nasal passages are constantly exposed to both air- and bloodborne foreign compounds. In particular, the olfactory mucosa is demonstrated to be susceptible to a variety of drugs and chemicals. In this thesis, mechanisms involved in tissue-selective toxicity in the olfactory mucosa of rodents have been investigated using the olfactory toxicant 2,6-dichlorophenyl methylsulphone (2,6-diClPh-MeSO2) as a model compound. Comparative studies were performed with the non-toxic 2,5-dichlorophenyl methylsulphone (2,5-diClPh-MeSO2) and the reasons for the strikingly different toxicity were investigated. A strong bioactivation and protein adduction of 2,6-diClPh-MeSO2 in olfactory microsomes and S9-fractions of rodents was demonstrated. In contrast, no significant metabolic activation of 2,5-diClPh-MeSO2 was observed and the bioactivation in the liver for both chlorinated isomers was negligible. In vitro studies with recombinant yeast cell microsomes expressing mouse cytochrome P450 2A5 (CYP2A5) demonstrated a metabolic activation of 2,6-diClPh-MeSO2. The 2,6-diClPh-MeSO2-induced lesions and CYP2A5 expression preferentially occurred in Bowman’s glands and sustentacular cells of the olfactory mucosa. A significant depletion of glutathione (GSH) in the olfactory mucosa was demonstrated in vivo, while no changes were observed in the liver. There was a rapid induction of the endoplasmic reticulum (ER)-specific chaperone Grp78, activation of the ER-specific caspase-12 and the downstream caspase-3 in the Bowman’s glands. Electron microscopy revealed swelling of ER and mitochondria and a lost integrity of the Bowman’s glands. Based on these results, the proposed mechanism for 2,6-diClPh-MeSO2-induced toxicity in the olfactory mucosa is bioactivation by CYP2A5 into a reactive intermediate causing protein adduction and GSH-depletion. This is initiating a sequence of downstream events of ER-stress, changes in ion homeostasis, ultrastructural organelle disruption and apoptotic signalling. In spite of the initial apoptotic signals, the terminal phase of apoptosis seemed to be blocked and necrotic features occurred. The predominant expression of CYP2A5 in the olfactory mucosa is proposed to play a key role for the tissue- and cell-specific toxicity induced by 2,6-diClPh-MeSO2.
13

Effects of retinoic acid in the mouse olfactory sensory systems /

Hörnberg, Maria, January 2007 (has links)
Diss. (sammanfattning) Umeå : Univ., 2007. / Härtill 4 uppsatser.
14

Comprimento telomérico no sistema nervoso central de um modelo de doença de Alzheimer tratado com lí­tio / Telomere length in the central nervous system of a model for Alzheimer\'s disease treated with lithium

Giancarlo de Mattos Cardillo 02 April 2018 (has links)
Telômeros são complexos DNA-proteína presentes nas extremidades dos cromossomos. Os telômeros se encurtam a cada divisão celular, sendo o comprimento telomérico, portanto, considerado um biomarcador do envelhecimento celular. Esse encurtamento é vinculado a diversas doenças relacionadas à idade avançada. Na doença de Alzheimer (DA), têm sido associados com diversas vias fisiopatológicas, como a neuroinflamação e o estresse oxidativo, porém seus mecanismos ainda são pouco conhecidos. A maioria dos estudos sobre comprimento telomérico na DA é realizada em DNA leucocitário, pouco se sabendo sobre seu estado no sistema nervoso central. O lítio é um importante estabilizador de humor, com efeitos neuroprotetores amplamente evidenciados, mas pouco se sabe sobre seu efeito na manutenção do comprimento telomérico. O objetivo do presente estudo foi avaliar o efeito do tratamento crônico com lítio no comprimento telomérico em diferentes regiões cerebrais (córtex parietal, hipocampo e epitélio olfatório) de camundongos triplo transgênicos para DA (3xTg-AD) e selvagens. Dezoito animais transgênicos e 22 selvagens foram tratados por oito meses com ração contendo 1,0 g (Li1) ou 2,0 g (Li2) de carbonato de lítio/kg, ou ração padrão (Li0). O comprimento telomérico do DNA extraído destes tecidos foi quantificado por PCR em tempo real. O tratamento crônico com lítio foi associado a telômeros mais longos no córtex parietal (Li1, p=0,04) e hipocampo (Li2, p=0,02) dos camundongos 3xTg-AD comparados com os respectivos selvagens. Nossos achados sugerem que o tratamento crônico com lítio afeta a manutenção do comprimento telomérico, mas que a magnitude desse efeito depende da concentração de lítio ministrada e das características do tecido envolvido. Esse efeito foi apenas observado quando comparando os animais triplo transgênicos com os selvagens, indicando que a presença da patologia, no caso a DA, se faz necessária para a modulação do comprimento telomérico promovida pelo lítio / Telomeres are DNA-protein complexes present in the extremities of chromosomes. Telomeres shorten at each cell division, being the telomere length, therefore, considered a cell aging biomarker. This telomere shortening is associated to several age-related diseases. In Alzheimer\'s disease (AD), telomere length has been linked to several pathophysiological pathways, such as neuroinflammation and oxidative stress, though its mechanism are still poorly understood. Majority of studies regarding telomere length in AD are based in leucocyte DNA, with little information about its status in the central nervous system. Lithium is an important mood stabilizer, with neuroprotective effects widely evidenced, but little is known about its effects in telomere length maintenance. The objective of this present study was to evaluate the effect of chronical lithium treatment on telomere length in different brain regions (parietal cortex, hippocampus and olfactory epithelium) of wild type and triple transgenic mice model for AD (3xTg-AD). Eighteen transgenic and 22 wild type male mice were treated for eight months with chow containing 1.0g (Li1) or 2.0g (Li2) of lithium carbonate/kg, or standard chow (Li0). Telomere length of extracted DNA from theses tissues was quantified by real-time PCR. Chronic lithium treatment was associated with longer telomeres in the parietal cortex (Li1, p=0.04) and in the hippocampus (Li2, p=0.02)of 3xTg-AD compared with the respective wild type.Our findings suggest that chronic lithium treatment does affect telomere maintenance, but the magnitude of this effect depends on the working concentrations of lithium and characteristics of the involved tissue. This effect was only observed when comparing triple transgenic with wild type mice, suggesting that the presence of AD pathology was required for the lithium modulation of telomere length
15

Distribuição do neuroepitélio olfatório em concha média e superior em cadáveres humanos / Distribution of olfactory neuroepithelium in the middle and superior turbinate of human cadavers

Fabio de Rezende Pinna 03 September 2008 (has links)
INTRODUÇÃO: A biópsia do neuroepitélio olfatório (NeuO) oferece perspectivas para aplicações terapêuticas tanto em doenças do olfato como doenças neurodegenerativas. Uma coleta bem sucedida desse tecido in vivo ainda não é rotina, devido á carência de estudos sobre a distribuição do NeuO em conchas superior (CS) e média (CM). Neste trabalho, descrevemos a distribuição do NeuO na CS e CM em cadáveres a partir da retirada integral dessas estruturas e posterior análise histológica por coloração de hematoxilina e eosina (HE) e imunoistoquímica. Além disso, também analisamos a influência do sexo, idade e lateralidade no grau de presença do NeuO nas CS e CM. CASUÍSTICA E MÉTODOS: Estudo anatômico prospectivo realizado de março de 2006 a janeiro de 2008. A CS e a CM foram endoscopicamente retiradas de um total de 25 cadáveres frescos com menos de 12 horas de óbito. Cada concha foi seccionada na metade de seu comprimento ântero-posterior. Assim, cada um dos 25 cadáveres deu origem a oito fragmentos de mucosa de regiões anatômicas distintas, totalizando 200 lâminas para análise tanto por coloração de HE como por reação de imunoistoquímica. Nas lâminas coradas por HE, classificamos a distribuição do NeuO em graus 0, 1, 2, 3, 4, sendo que a análise foi realizada por 3 patologistas de forma cega. Para imunoistoquímica, só obtivemos positividade com a proteína S-100. A concordância entre os três patologistas foi avaliada aos pares utilizando-se o coeficiente de Kappa. A distribuição do NeuO foi analisada de acordo com a idade, sexo, tempo de óbito, simetria entre as fossas nasais e acurácia da imunoistoquímica. RESULTADOS: Pela HE na CS, o NeuO esteve presente em 82,9% das vezes e, na CM, em 17,1%. Na CS, o NeuO foi detectado em 82,9 % das lâminas, 4,9 vezes a prevalência na CM, que foi de 17,1 % das lâminas (p < 0,001). Pela imunoistoquímica, foi possível encontrar NeuO em um total de 15 fragmentos. Desses, 10 (20%) eram da metade posterior da CS e cinco (7,6%) da metade anterior da CS. Pelo cálculo da razão de prevalência, temos que a chance de encontrar NeuO é 4,9 vezes maior na CS do que na CM (IC95%: 3,3 7,4). Dos 15 fragmentos com marcação positiva para proteína S-100, sete corresponderam aos que tinham uma distribuição grau 3 (>50% e 75%) pela HE e outros sete aos que tinham uma distribuição grau 4 (acima de 75%). Somente um fragmento teve marcação positiva para imunoistoquímica no grupo 2 (entre 26 e 50%) na HE. A proteína S-100 apresentou uma sensibilidade de 13,5% e especificidade de 100% para detecção de NeuO. Não houve diferença estatisticamente significante na prevalência de NeuO quando os fragmentos foram divididos de acordo com o sexo, idade de óbito e lado da fossa nasal. No entanto, ao analisarmos a presença de NeuO de acordo com o grau de distribuição entre cada lado, não se percebe uma concordância. CONCLUSÕES: A quantidade total de NeuO foi simetricamente distribuída entre as fossas nasais, mas não houve uma concordância entre os lados quanto à maneira como o NeuO está distribuído. O NeuO apresenta maior probabilidade de ser encontrado na metade posterior de CS. A HE é um método eficaz para distinção entre NeuO e epitélio respiratório, devido a grande concordância entre três patologistas distintos. / INTRODUCTION: Olfactory neuroepithelium (ON) biopsy provides perspectives for several therapeutic applications, both in disorders of olfaction and in neurodegenerative diseases. Successful in vivo collection of ON is still not routine, due to a dearth of studies on ON distribution in the superior and middle turbinate (ST and MT respectively). This study describes the distribution of ON in cadaver ST and MT as determined by complete endoscopic removal of turbinates and histological analysis with hematoxylin and eosin (H&E) and immunohistochemical staining. We also analyzed the influence of gender, age, and naris side on the extent to which ON is present in the superior and middle turbinate. CASE SELECTION AND METHODS: We conducted a prospective anatomical study from March 2006 to January 2008. The superior and middle turbinates of 25 fresh cadavers (less than 12 hours post-mortem) were removed endoscopically. Each turbinate was halved into anterior and posterior fragments. Eight anatomically distinct fragments were therefore obtained from each of the 25 cadavers for a total of 200 specimens, which were analyzed through H&E staining and immunohistochemistry. Hematoxylin and eosin-stained slides were subjected to blind examination by three independent pathologists; ON distribution was graded on a fivepoint numeric scale (grade 0, 1, 2, 3, or 4). Immunohistochemistry was only positive through S-100 staining. Pairwise agreement between pathologists was assessed by means of the Kappa coefficient. The distribution of ON was analyzed regarding age, gender, time elapsed between death and specimen harvesting, symmetry between nares, and accuracy of immunohistochemistry results. RESULTS: In H&E-stained slides, olfactory neuroepithelium was present in 82.9% of ST and 17.1% of MT specimens; prevalence in the superior turbinate was therefore 4.9-fold greater (p < 0.001). Immunohistochemical analysis was able to identify ON in 15 fragments, 10 of which (20%) were from the posterior half of the superior turbinate; the remaining five specimens (7.6%) were from the anterior ST. According to prevalence ratio, the odds of finding ON are 4.9 times greater in superior turbinate than in the middle turbinate (CI, 95%; 3.37.4). Of the 15 immunohistochemistry-positive fragments, seven were assigned distribution grade 3 (>50% and 75% presence of ON) on H&E staining seven others were graded 4 (>75% presence of ON). A single immunohistochemistrypositive fragment was found to have grade 2 ON distribution (i.e., it contained 26% to 50% olfactory neuroepithelium) on H&E staining. S-100 staining showed a sensitivity of 13.5% and specificity of 100% for ON detection. There was no statistically significant difference in ON prevalence when fragments were compared according to gender, age at time of death, and naris side. However, when we analyzed ON presence according to the degree of ON distribution in each side, we found no concordance. CONCLUSIONS: Total ON was distributed symmetrically between nares, but we found no concordance between sides in the manner in which ON is distributed. ON is most likely to be found in the posterior half of the superior turbinate. Hematoxylin and eosin (H&E) staining is an effective method for distinguishing ON from respiratory epithelium, as shown by high inter-rater agreement among three independent pathologists
16

Olfactory Transfer of Analgesic Drugs After Nasal Administration

Espefält Westin, Ulrika January 2007 (has links)
Nasal administration of analgesics for achieving rapid pain relief is currently a topic of great interest. The blood-brain barrier (BBB) restricts access to the central nervous system (CNS) for several central-acting drugs, such as morphine and dihydroergotamine, which results in a substantial effect delay. Evidence for the olfactory transfer of drugs from the nasal cavity to the CNS after nasal administration, bypassing the BBB, is available for both animals and humans. The aims of this thesis were to study the olfactory transfer of morphine to the CNS after nasal administration, and to compare the nasal transport of analgesic drugs across nasal respiratory and olfactory mucosa. In vivo studies in rodents demonstrated that morphine is transferred via olfactory pathways to the olfactory bulbs and the longitudinal fissure of the brain after nasal administration. Further, olfactory transfer of morphine significantly contributed to the early high morphine brain hemisphere concentrations seen after nasal administration to rats. Olfactory transfer was tracked by collecting and analysing brain tissue and blood samples after right-sided nasal administration and comparing the results to the situation after i.v. administration. The olfactory transfer was also visualised by brain autoradiography. In vitro studies indicated that the olfactory mucosa should not be a major barrier to the olfactory transfer of dihydroergotamine or morphine, since transport of these drugs was no more restricted across the olfactory mucosa than across the nasal respiratory mucosa. The in vitro studies were performed using the horizontal Ussing chamber method. This method was further developed to enable comparison of drug transport across nasal respiratory and olfactory mucosa which cannot be achieved in vivo. In conclusion, these analgesic drugs showed potential for olfactory transfer, and access to the CNS by this route should be further investigated in humans, especially for the drugs with central effects that are currently under development for nasal administration.
17

Implication de MMP-2 dans les propriétés des cellules engainantes de la muqueuse olfactive et dans la réparation des lésions de la moelle épinière : études in vitro et in vivo

Gueye, Yatma 04 July 2011 (has links)
Lorsque le système nerveux central des mammifères est lésé, un ensemble de réactions secondaires impliquant l’inflammation et une gliose réactive conduit à la formation d’une cicatrice gliale qui inhibe la régénération axonale. Dans le cas d’une lésion de la moelle épinière l’absence de réparation efficace des réseaux axonaux lésés peut conduire à la paraplégie ou à la tétraplégie. Aujourd’hui on estime à plus de 2,5 millions le nombre d’individus dans le monde souffrant de ces handicaps et il n’existe à ce jour aucun traitement validé pour améliorer la situation des patients. Cependant, certaines approches de thérapie moléculaire, cellulaire, et de réadaptation semblent toutefois prometteuses sur modèle animal. La dégradation des chondroitines sulfates protéoglycanes (CSPGs), principales protéines inhibitrices de la cicatrice gliale, par clivage des coeurs protéiques et ou des chaînes latérales glycosaminoglycanes favorise la régénération axonale et entraîne une récupération fonctionnelle. Des études ont montré que la métalloprotéase matricielle MMP&#8208;2 est capable de dégrader le coeur protéique de ces CSPGs. Par ailleurs, les cellules engainantes de la muqueuse olfactive (CEOs) occupent une place privilégiée parmi les types cellulaires proposés dans la thérapie cellulaire en favorisant la croissance axonale et la récupérationfonctionnelle après lésion de la moelle épinière. Cependant, les mécanismes qui sous&#8208;tendent les propriétés régénératrices des CEOs restent essentiellement inconnus. Dans notre Thèse, nous présentons nos travaux en trois parties. Dans la première, nous montrons in vitro que : i) les CEOs en culture primaire secrètent des taux élevés de MMP&#8208;2, au moins en partie active ; ii) les gélatinases MMP&#8208;2 et MMP&#8208;9 présentent une sécrétion vésiculaire golgi&#8208;dépendante; iii) la distribution des vésicules contenant les MMPs est liée à celle du cytosquelette et des moteurs moléculaires qui participent probablement à une sécrétion focalisée de ces molécules en fonction d’interactions entre le milieu extracellulaire et le cytosquelette ; iv) les MMPs peuvent avoir une distribution nucléaire dans les CEOs ; v) MMP&#8208;2 jouerait un rôle dans la migration des CEOs, un processus important dans leurs capacités à réparer le tissu nerveux. Dans la seconde partie de notre thèse, nous avons développé un modèle de cicatrice gliale in vitro et nous montrons que : i) la migration des cellules astrocytaires de la cicatrice gliale in vitro est sensible aux effets des inhibiteurs des MMPs, contrairement aux cellules microgliales ; ii) les CEOs lèvent l’inhibition de croissance axonale due aux cellules astro&#8208;microgiales ; iii) le potentiel des CEOs à créer un environnement permissif à la croissance axonale serait lié aux gélatinases sécrétées par ces cellules, en particulier MMP&#8208;2. Dans la troisième partie de notre Thèse, nous avons évalué in vivo si MMP&#8208;2 contribuait aux effets bénéfiques des CEOs. Nous montrons pour la première fois, dans un model animal d’hémisection de la moelle épinière, et en utilisant des approches anatomiques, électrophysiologiques et d’analyse de la locomotion, qu’une administration chronique de MMP&#8208;2 recombinante : i) augmente le nombre et le diamètre des axones du coté distal du site de lésion ; ii) restaure la réponse évoquée du reflexe&#8208;H distal au site de lésion ; iii) améliore la réponse respiratoire à la fatigue musculaire induite électriquement et, iv) le plus important, améliore la récupération de la locomotion. L’ensemble de notre travail suggère que MMP&#8208;2 sécrétée par les CEOs jouerait un rôle important des les propriétés bénéfiques de ces cellules lorsqu’elles sont transplantées dans des sites de lésions de la ME, et que cette MMP présente un réel potentiel thérapeutique qui reste à explorer. / When the mammalian central nervous system is injured, a set of secondary reactions involving inflammation and reactive gliosis leads to the formation of a glial scar that inhibits axonal regeneration. In the case of a spinal cord lesion, the lack of effective repair of injured axonal networks can lead to paraplegia or quadriplegia. Today it is estimated that more than 2.5 million people are suffering from these handicaps worldwide, and there is as yet no validated treatment to improve the situation of patients. However, based on animal models, some molecular, cellular, and rehabilitation therapy approaches seem promising. Degradation of chondroitin sulfate proteoglycan (CSPG), the main inhibitory protein of the glial scar, by cleavage of either the protein core or side chains glycosaminoglycans, promotes axonal regeneration and leads to functional recovery. Studies have shown that the matrix metalloproteinase MMP-2 is capable of degrading the core protein of the CSPG. In addition, olfactory mucosa ensheathing cells (OECs) represent the most promising cell type for promoting axonal growth and functional recovery after spinal cord injury. However, the mechanisms underlying the regenerative properties of OECs remain essentially unknown. Here, we present our work in 2 parts. First, we show in vitro that: i) OECs in primary culture secrete high levels of active MMP-2; ii) both gelatinases, MMP-2 and MMP-9, have a vesicular Golgi-dependent secretion; iii) the distribution of vesicles containing the MMPs is linked to cytoskeleton and molecular motors distribution, which are probably involved in focused secretion of these molecules; iv) MMPs may have a nuclear distribution in OECs; v) MMP-2 plays a role in the migration of EOCs, an important process in their ability to repair nerve tissue. In the second part of my work, we evaluated whether the MMP-2 contributed to the beneficial effects of EOCs. We used an in vivo approach and we show for the first time, in an animal model of hemisection of the spinal cord, and using anatomical, electrophysiological analysis of locomotion approaches, that a chronic administration of recombinant MMP-2: i) increases the number and diameter of axons in the distal side of the site of injury; ii) restores the response-evoked H-reflex distal to the lesion site, iii) enhances the respiratory response to electrically-induced muscle fatigue, and iv) most importantly, improves the recovery of locomotion. All our work suggests that MMP-2, secreted by the EOCs, plays an important role in the recovery properties of these cells, when transplanted into spinal cord lesions, and that this MMP has a real therapeutic potential that remains to be explored.

Page generated in 0.2512 seconds